The size of the Europe Interventional Neurology Market was worth USD 536.6 million in 2020 and estimated to reach $ 829.6 million by the end of 2025, with a growing potential of 8.80 %. Europe Interventional Neurology market is expected to account for the second-largest share in the market due to a favorable reimbursement scenario and advancements in technology.
Interventional neurology is a procedure that refers to a specific kind of endovascular procedure within the spinal cavity, imaging guidance within the vessels of the brain, special microcatheter, utilizing minimally invasive techniques, guidewire to treat stroke and various neurological disorders. Arteries weakening can create brain aneurysms and increase the risk of intracranial bleeding. The neurovascular disease is the leading cause of disability in adults.
Europe Interventional Neurology Market is mainly driven by growth in the patient population, advancements in technology, favorable reimbursement plans, significant adoption of neurovascular devices among neurosurgeons, and increasing R & D investments. However, lack of skilled neurosurgeons, stringent regulatory bodies are hampering the growth of the market.
This market research report on the European Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories.
Some of the key players in Europe Interventional Neurology Market are Stryker Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Microport Scientific Corporation, and Medikit Co., Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Embolization and Coiling
5.1.3 Angioplasty
5.1.4 Carotid Stenting
5.1.5 Neurothrombectomy
5.1.6 Micro support devices
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By Technology
5.1.9 Market Attractiveness Analysis, By Technology
5.1.10 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Carotid Stent
5.2.3 Microcatheter
5.2.4 Flow Diversion
5.2.5 Microguidewires
5.2.6 Suction Device
5.2.7 stenting systems
5.2.8 Clot Retrieval
5.2.9 Others
5.2.10 Y-o-Y Growth Analysis, By Product
5.2.11 Market Attractiveness Analysis, By Product
5.2.12 Market Share Analysis, By Product
5.3 End-users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory centers
5.3.4 Neurology clinics
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End-users
5.3.7 Market Attractiveness Analysis, By End-users
5.3.8 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By End-users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Stryker Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic plc
8.3 Johnson & Johnson
8.4 Terumo Corporation
8.5 Penumbra Inc.
8.6 Abbott Laboratories
8.7 Merit Medical Systems Inc.
8.8 W. L. Gore & Associates Inc.
8.9 Microport Scientific Corporation
8.10 Medikit Co., Ltd
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
